Reply to ‘Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma’ (Am Surg 2012;78:225-9).

Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated.

Effects of oxidative stress on mitochondrial content and integrity of human anastomotic colorectal dehiscence: a preliminary DNA study.